Release Date: 23/01/14 17:31 Summary: Quarterly Cashflow Report Price Sensitive: No Download Document 114.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%